Dinutuximab (Ch14.18, tradename Unituxin) and dinutuximab beta (tradename Qarziba) are monoclonal antibodies used as a second-line treatment for children...
16 KB (1,470 words) - 01:41, 18 May 2024
mafodotin Bermekimab Blinatumomab Cemiplimab Cosibelimab Daratumumab Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab...
12 KB (821 words) - 06:14, 23 December 2024
Catumaxomab L01FX04 Ipilimumab L01FX05 Brentuximab vedotin L01FX06 Dinutuximab beta L01FX07 Blinatumomab L01FX08 Elotuzumab L01FX09 Mogamulizumab L01FX10...
13 KB (935 words) - 04:36, 23 December 2024
humanized serum amyloid P component Dinutuximab Unituxin mab chimeric GD2 ganglioside Y neuroblastoma Dinutuximab beta Qarziba mab chimeric GD2 ganglioside...
138 KB (4,154 words) - 05:18, 17 December 2024
mafodotin Bermekimab Blinatumomab Cemiplimab Cosibelimab Daratumumab Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab...
12 KB (758 words) - 23:46, 14 March 2024
According to the Amyloid hypothesis, the accumulation of extracellular amyloid beta peptides (Aβ) into plaques via oligomerization leads to hallmark symptomatic...
59 KB (4,170 words) - 07:03, 20 October 2024
protein of a minretumomab single-chain variable fragment and the enzyme beta-lactamase. Iodine (125I) minretumomab is an iodine-125 radiolabelled derivative...
5 KB (368 words) - 15:29, 21 August 2024